Impaired polyclonal t cell cytolytic activity

Arthritis & Rheumatism

Volumn 38, Issue 4, 1995, Pages 506-516

  Stohl, William ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYTOTOXIC AGENT; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; DAUDI CELL; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANTIGENS, CD3; ANTIRHEUMATIC AGENTS; COHORT STUDIES; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; REFERENCE VALUES; RHEUMATIC DISEASES; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0028921921     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780380408     Document Type: Article

References (35)

1. T lymphocytes, cytokines, and immune regulation in systemic lupus erythematosus
2. Role of cytotoxic T lymphocytes in the prevention of lupus‐like disease occurring in a murine model of graft‐versus‐host disease
3. Allosuppressor‐ and allohelper‐T cells in acute and chronic graft‐versus‐host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes
4. 1‐reactive allohelper but no allosuppressor T cells
5. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease
6. + T cell clones to induce noncognate contact‐dependent polyclonal B cell activation
7. Impaired generation of polyclonal T cell‐mediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus
8. The 1982 revised criteria for the classification of systemic lupus erythematosus
9. Derivation of the SLEDAI: a disease activity index for lupus patients
10. Definition, incidence, and clinical description of flare in systemic lupus erythematosus: a prospective cohort study
11. Induction of T cell‐dependent B cell differentiation by anti‐CD3 monoclonal antibodies
12. Differential immunomodulation by anti‐CD2 monoclonal antibodies of anti‐CD3‐induced T cell activation: dependence upon the individual anti‐CD3 monoclonal antibody used for activation
13. Generation of cytolytic activity with anti‐CD3 monoclonal antibodies involves both IL‐2‐independent and ‐dependent components
14. The mitogenic activity of OKT3 and anti‐Leu 4 monoclonal antibodies: a comparative study
15. Human T lymphocyte proliferation induced by a pan‐T monoclonal antibody (anti‐Leu 4): heterogeneity of response is a function of monocytes
16. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human cells
17. The role of antigen‐presenting B cells in T cell priming in vivo: studies of B cell‐deficient mice
18. Molecular basis for a polymorphism involving Fc receptor II on human monocytes
19. Molecular basis for a polymorphism of human Fcγ receptor II (CD32)
20. Induction of nonspecific cytotoxicity by monoclonal anti‐T3 antibodies
21. Antigen‐specific cytotoxic T cell and antigen‐specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3
22. Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus
23. T lymphocyte subsets in systemic lupus erythematosus: correlations with corticosteroid therapy and disease activity
24. Correlation between the phenotype and the functional capacity of activated T cells in patients with active systemic lupus erythematosus
25. Depression of cellular‐mediated immunity in systemic lupus erythematosus: relation to disease activity
26. T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity
27. Suppressor T‐cell abnormality in idiopathic systemic lupus erythematosus
28. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus
29. Cellular mechanism of DNA‐specific antibody synthesis by lymphocytes from systemic lupus erythematosus patients
30. Failure of autologous mixed lymphocyte reactions between T and non‐T cells in patients with systemic lupus erythematosus
31. Deficient autologous mixed lymphocyte reactions correlate with disease activity in systemic lupus erythematosus and rheumatoid arthritis
32. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis
33. Immunosuppressive effects of low doses of glucocorticoids: effects on autologous and allogeneic mixed leukocyte reactions
34. Interleukin 2 regulated expression of its receptor and synthesis of gamma interferon by human T lymphocytes
35. A revised estimate of twin concordance in systemic lupus erythematosus